The symposia of excellence

Since 1973 the World Symposium on Pulmonary Hypertension harmonizes research progresses on pulmonary hypertension.

Dear Colleagues,

We are pleased to inform you that the next 7th World Symposium on Pulmonary Hypertension (7th WSPH) will take place in Barcelona, Spain, from Saturday June 29th to Monday July 1st 2024.

Traditionally, the PH World Symposia series, initiated in Geneva in 1973 and held every 5 years after the Evian edition in 1998 (Venice 2003, Dana Point 2008, Nice 2013, Nice 2018), has marked the progress in pulmonary hypertension science and has identified fruitful directions for future developments. The published supplements, including the symposia proceedings, constitute a collection of articles among the most cited in this scientific area.

Each new edition of the WSPH series has experienced an increase in attendance, signifying the growing interest of this field’s stakeholders. More than 1200 international physicians, scientists and other health care workers attended the 5th WSPH – Nice 2013, and more than 1500 attended the 6th WSPH – Nice 2018.

The objectives of the 7th WSPH will be as follows:

  • Review by expert task forces of the major advances in pulmonary vascular science over the past 6 years
  • Analysis of the available evidence in basic and clinical areas
  • Identification of the evidence gaps in different areas, and proposals for future collaborative research programs
  • Production of documents by the task forces that summarize the results of pre-symposium meetings (previous 18-24 months)
  • Discussion at the symposium sessions by the task forces of documents, along with worldwide experts and with other stakeholders
  • Final drafting of peer reviewed papers that will be included in a supplement in a prestigious medical journal to facilitate the dissemination of the 7th WSPH work.

15 Task Forces have been identified:

  1. Patient perspective
  2. Pathobiology and mechanisms of disease
  3. Genetics and genomics
  4. Pathophysiology of right ventricle and pulmonary vascular Interaction 
  5. Definition, classification, and diagnosis of pulmonary hypertension
  6. Emerging multimodality imaging techniques of pulmonary circulation 
  7. PAH risk stratification and treatment goals
  8. Transplantation and bridging, and support technologies 
  9. PH management in special conditions 
  10. PAH treatment algorithm
  11. Clinical trial designs, endpoints, and emerging therapies
  12. PH and left heart disease
  13. PH and chronic lung disease
  14. Chronic thromboembolic pulmonary disease
  15. Pediatric pulmonary hypertension

Our purpose is to foster with the Symposium constructive scientific interactions and collaborations in the field of Pulmonary Hypertension.

We look forward to meeting you in Barcelona for this important event.

The Symposium Organizing Committee

The Symposium Organizing Committee

Nazzareno Galiè
Bologna - Italy
Vallerie Victoria McLaughlin
Ann Arbor MI – USA
Lewis J. Rubin
La Jolla CA - USA
Gerald Simonneau
Paris - France
Marc Humbert
Paris - France

Connecting excellences

Task Forces Members
0
Task Forces
0
Attendees
0

Check The Agenda

The 7th WORLD SYMPOSIUM ON PULMONARY HYPERTENSION, Barcelona, Spain 29/06/2024 - 01/07/2024 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18.5 European CME credits (ECMEC®s).

Saturday, 29 June 2024

8:45 am
Opening Ceremony Plenary Hall
9:15 am
TF1 _ Patient perspective Plenary Hall
10:30 am
Coffee break and poster session
11:00 am
TF 2_Pathobiology and mechanisms of disease Plenary Hall
12:15 pm
Best Poster Award Ceremony Plenary Hall
12:45 pm
Lunch and poster session
1:45 pm
TF 3_Genetics and genomics Plenary Hall
3:00 pm
TF 4_Pathophysiology of right ventricle and pulmonary vascular interaction Plenary Hall
4:15 pm
Coffee break and poster session
4:45 pm
TF 5_Definition, classification, and diagnosis of pulmonary hypertension Plenary Hall
6:00 pm
End of sessions

Sunday, 30 June 2024

9:00 am
TF 6_Emerging multimodality Imaging techniques of pulmonary circulation Plenary Hall
10:15 am
Coffee break and poster session
10:45 am
TF 7_PAH risk stratification and treatment goals Plenary Hall
12:00 pm
TF 8_Transplantation and bridging, and support technologies Plenary Hall
1:15 pm
Lunch and poster session
2:15 pm
TF 9_PH Management in special conditions Plenary Hall
3:30 pm
TF 10_PAH treatment algorithm Plenary Hall
4:45 pm
Coffee break and poster session
5.15 pm
TF 11_Clinical trial designs, endpoints, and emerging therapies Plenary Hall
6:30 pm
End of sessions

Monday, 1 July 2024

8:00 am
TF 12_PH and left heart disease Plenary Hall
9:15 am
TF 13_PH and chronic lung disease Plenary Hall
10:30 am
Coffee break and poster session
11:00 am
TF 14_Chronic thromboembolic pulmonary disease Plenary Hall
12:15 pm
TF 15_Pediatric pulmonary hypertension Plenary Hall
1:30 pm
Conclusions Plenary Hall
1:45 pm
Lunch and poster session Plenary Hall
2:45 pm
End of the Symposium

Endorsements

1 ERN-LUNG LOGO - Kopie

Registration fees

Fee within February 15, 2024

Early Bird
  • 🟡POSTER PRESENTERS € 550,00
  • 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL NURSES € 550,00
  • 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL PHYSICIANS € 1.000,00
  • 🟡NO-UNIVERSITY OR NO-PUBLIC/PRIVATE HOSPITAL PHYSICIANS AND PHARMA COMPANIES REPRESENTATIVES € 3.000,00
  • 🟡REDUCED FEE FOR STAFF MEMBERS OF THE SPONSOR COMPANIES € 1.500,00
  • 🟡MEMBERS OF PATIENTS ASSOCIATIONS** € 550,00

Registration Fees (VAT included)

After February 15, 2024

Standard Fee
  • 🟡POSTER PRESENTERS € 550,00
  • 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL NURSES € 550,00
  • 🟡UNIVERSITY & PUBLIC/PRIVATE HOSPITAL PHYSICIANS € 1.300,00
  • 🟡NO-UNIVERSITY OR NO-PUBLIC/PRIVATE HOSPITAL PHYSICIANS AND PHARMA COMPANIES REPRESENTATIVES € 3.400,00
  • 🟡REDUCED FEE FOR STAFF MEMBERS OF THE SPONSOR COMPANIES € 1.750,00
  • 🟡MEMBERS OF PATIENTS ASSOCIATIONS** € 550,00

Registration Fees (VAT included)

Timeline

Abstract submission
January 9  January 17, 2024

Communication of acceptance of abstracts
January 31, 2024

Early bird registrations 
February 15, 2024

Deadline for refund requests for registrations   
May 20, 2024

Online registrations open until
June 20, 2024

No refund will be provided for any cancellation including no-shows
from May 21, 2024

International Barcelona Convention Center ENTRANCE B

Get Direction to the Event Hall

With the non conditioning sponsorship of

CVS and e4ethics ID EMT 36574

EthicalMedTech is a unique platform supported by MedTech Europe and dedicated to ethics and compliance projects in the healthcare sector. It is hosting major industry compliance initiatives – including EFPIA’s evaluation platform for European medical conferences since January 2021.

https://www.ethicalmedtech.eu/conference-vetting-system/search-events/

The Organizing Committee warmly discourages satellite symposia or any kind of meeting involving the attendees organized by industry in Barcelona before, during or after the Symposium.

Chiesi Logo - 1.Primary

Subscribe Newsletter

Hurry Up!

Limited tickets available

Last time our tickets sold fast so don’t miss.

@2024 7th WORLD SYMPOSIUM ON PULMONARY HYPERTENSION. All Rights Reserved.